AuriPro

1 stories · following the connections

Business

Otonomy Announces Phase 3 Clinical Trial Plan for OTIPRIO™ in Otitis Externa Patients Based on Successful End-of-Phase 2 Review by FDA

By Nasdaq OMXApr 18, 2016, 11:30 AM UTC